IOL Chemicals & Pharmaceuticals Ltd
IOL Chemicals & Pharmaceuticals Ltd Share Price Today: Live Updates & Key Insights
Get insights on IOL Chemicals & Pharmaceuticals Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
IOL Chemicals & Pharmaceuticals Ltd Share Price Chart
IOL Chemicals & Pharmaceuticals Ltd Fundamentals
Traded Volume: 5,08,129
Market Cap(Cr): 2,651
Avg Traded Price 90.58
1 Year return 32.14%
Upper Circuit 91.4
Lower Circuit 90
P/E TTM 23.00
P/B Ratio 4.00
Traded Value(Cr) 458.94
EPS TTM 3.947
Book value 3.947
Dividend 1.00%
IOL Chemicals & Pharmaceuticals Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights IOL Chemicals & Pharmaceuticals Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the IOL Chemicals & Pharmaceuticals Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W -7.90%
1M -4.72%
3M -7.89%
1Y +32.14%
YTD +11.34%
IOL Chemicals & Pharmaceuticals Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights IOL Chemicals & Pharmaceuticals Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday 6.86L
Day Before Yesterday 5.51L
1W Avg 8.11L
1M Avg 23.10L
3M Avg 47.07L
IOL Chemicals & Pharmaceuticals Ltd Technical Details
IOL Chemicals & Pharmaceuticals Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 null
Support 2 null
Support 3 null
Pivot Point : null
Resistance 1 null
Resistance 2 null
Resistance 3 null
IOL Chemicals & Pharmaceuticals Ltd Corporate Actions
IOL Chemicals & Pharmaceuticals Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on IOL Chemicals & Pharmaceuticals Ltd’s capital allocation strategies.
All
Ex-Date 11-Mar-2025 Type S Description share@1:5.00 Record Date 11-Mar-2025 Ratio 1:5.00
Ex-Date 18-Feb-2025 Type D Description 4.00/share@40.00% Record Date 18-Feb-2025 Ratio 40.00
Ex-Date 16-Feb-2024 Type D Description 5.00/share@50.00% Record Date 16-Feb-2024 Ratio 50.00
Ex-Date 17-Feb-2023 Type D Description 4.00/share@40.00% Record Date 17-Feb-2023 Ratio 40.00
Ex-Date 15-Feb-2022 Type D Description 4.00/share@40.00% Record Date 16-Feb-2022 Ratio 40.00
Ex-Date 08-Sep-2021 Type D Description 2.00/share@20.00% Record Date - Ratio 20.00
Ex-Date 17-Nov-2020 Type D Description 4.00/share@40.00% Record Date 18-Nov-2020 Ratio 40.00
Ex-Date 18-Mar-2020 Type D Description 3.00/share@30.00% Record Date 19-Mar-2020 Ratio 30.00
Dividends
Announcement Date 18-Feb-2025 Ex Dividend Date 18-Feb-2025 Dividend(%) 40
Announcement Date 16-Feb-2024 Ex Dividend Date 16-Feb-2024 Dividend(%) 50
Announcement Date 17-Feb-2023 Ex Dividend Date 17-Feb-2023 Dividend(%) 40
Announcement Date 15-Feb-2022 Ex Dividend Date 15-Feb-2022 Dividend(%) 40
Announcement Date 08-Sep-2021 Ex Dividend Date 08-Sep-2021 Dividend(%) 20
Announcement Date 17-Nov-2020 Ex Dividend Date 17-Nov-2020 Dividend(%) 40
Announcement Date 18-Mar-2020 Ex Dividend Date 18-Mar-2020 Dividend(%) 30
Bonus
No Bonus has been declared by IOLCP
Splits
Record Date 11-Mar-2025 Split Date 11-Mar-2025 Face Value (Before/After) 10.00/2.00
Others
Rights No Rights has been declared by IOLCP
IOL Chemicals & Pharmaceuticals Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares IOL Chemicals & Pharmaceuticals Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate IOL Chemicals & Pharmaceuticals Ltd's relative performance and valuation against major competitors.
Stock Name Gufic BioSciences Ltd ₹352.45 (+2.86%) M. Cap (Cr) 35.34 1 Yr Return (%) -13.10% P/E (TTM) 62.10 PB Ratio 6.16
Stock Name Unichem Laboratories Ltd ₹466.40 (-2.48%) M. Cap (Cr) 32.84 1 Yr Return (%) -45.80% P/E (TTM) 37.12 PB Ratio 1.34
Stock Name Hikal Ltd ₹224.98 (-1.46%) M. Cap (Cr) 27.74 1 Yr Return (%) -41.82% P/E (TTM) 274.66 PB Ratio 2.20
Stock Name IOL Chemicals & Pharmaceuticals Ltd ₹90.32 (-1.42%) M. Cap (Cr) 26.51 1 Yr Return (%) +32.14% P/E (TTM) 22.88 PB Ratio 1.60
Stock Name Alembic Ltd ₹98.51 (-0.44%) M. Cap (Cr) 25.30 1 Yr Return (%) -20.08% P/E (TTM) 7.81 PB Ratio 1.08
Stock Name SMS Pharmaceuticals Ltd ₹281.90 (-0.70%) M. Cap (Cr) 26.40 1 Yr Return (%) +17.80% P/E (TTM) 29.62 PB Ratio 4.43
Stock Name Solara Active Pharma Sciences Ltd ₹547.70 (-2.73%) M. Cap (Cr) 19.81 1 Yr Return (%) -28.07% P/E (TTM) 380.12 PB Ratio 2.23
IOL Chemicals & Pharmaceuticals Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by IOL Chemicals & Pharmaceuticals Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2025 178.68
PARTICULARS Investing Activities Mar 2025 -154.23
PARTICULARS Financing Activities Mar 2025 46.04
PARTICULARS Net Cash Flow Mar 2025 70.49
IOL Chemicals & Pharmaceuticals Ltd Shareholding Pattern
This shows the ownership breakdown of IOL Chemicals & Pharmaceuticals Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter 52.62%
Public 45.1%
Other Institutions 0.03%
FII 2.25%
Mutual Funds 0.02%
About IOL Chemicals & Pharmaceuticals Ltd
IOL Chemicals and Pharmaceuticals Limited, incorporated in September, 1986 is a renowned company in the Active PharmaceuticalIngredient (API) and specialty chemicals sectors. Its extensive expertise in both API and specialty chemicals strengthens the business model and opens doors to diversified growth opportunities.Within the API segment, IOL develops and supplies a wide range of essential products utilized by pharmaceutical companies worldwide for the production of key medicines. It serves as a global supplier of various APIs, including Ibuprofen, Metformin, Clopidogrel, Lamotrigine, Pantoprazole, and Fenofibrate, alongside other APIs, and maintains a significant presence in all major therapeutic categories.In the Specialty Chemicals division, IOL manufactures Ethyl Acetate, Iso Butyl Benzene (IBB), Mono Chloro Acetic Acid (MCA), and Acetyl Chloride. The Company is a leader in fostering green chemistry through its extensive production of Ethyl Acetate, a sustainable and environmentally friendly solvent. As one of the largest manufacturers globally, the Company plays a vital role in promoting the adoption of eco-friendly practices in various industries such as pharmaceuticals, printing, flexible packaging, adhesives, surface coatings, flavors, paints & lamination, and essences.The company has two manufacturing units namely API Unit and Chemical Unit located in Punjab. API Unit manufactures Ibuprofen with the installed Capacity of 10 MTPD. Chemical Unit manufactures organic chemicals such as Glacial Acetic Acid, Ethyl Acetate, Acetic Anhydride, Mono chloro acetic Acid, Acetyl Chloride and Iso butyl Benzene. The company is having their presence in over 40 countries across the world, which includes Bangladesh, Thailand, UAE, Syria, Singapore, Hong Kong, Pakistan, Egypt, and many others. They have strong business relationships with a number of prestigious clients such as Ranbaxy Labs, Dr Reddy. DS Group, Cipla, Uflex Industries, ITC Ltd, ICI Paints, Asian Paints, Pidillte, Rallis India, Hindustan Polymide, Gujarat Super Phosphate and Avon Organics Ltd etc.The capacity enhancement project and Multi Product PPIs Plant and other pharmaceutical intermediate products with a CAPEX of Rs 130 crore was completed in 2012. The Company undertook another project of multi product plant for manufacture active pharmaceutical ingredients and upgrading of R&D facilities involving a CAPEX of Rs 58.41 crore.G Drugs and Pharmaceuticals Limited (GDPL) was merged with Company, through The Board for Industrial and Financial Reconstruction (BIFR), vide its order dated 15 March 2012, with appointed date of 1 April 2010. The said Merger was made effective on 20 April 2012 and consequently GDPL ceased to exit from that date.During the current year 2016-17, the Company converted its existing multiple purpose plant into a dedicated ibuprofen manufacturing facility and resulting to its conversion, the ibuprofen manufacturing facility increased from 6200 TPA to 7200 TPA. During year 2017-18, Unit III to manufacture Fenofi brate, Clopidogrel and Lamotrigine Project was set up which costed Rs 16.48 crore. The company also setup Unit IV for manufacturing Metformin an anti-diabetic drug with a capacity of 3000 MT per annum with project cost of Rs 10.02 crore. It enhanced installed capacity of Ibuprofen from 7200 TPA to 10000 TPA by debottlenecking and re-engineering the plant in the month of August 2018.During year 2019, the Company has enhanced installed capacity of Metformin from 3,000 TPA to 4,000 TPA with a capex of Rs 2.71 crore; it set up Unit V o manufacture Clopidogrel Bisulphate & Fenofibrate with a capacity of 180 MT per annum with capex of Rs 19.26 crore; it further enhanced existing manufacturing facilities of Ibuprofen from 10,000 TPA to 12,000 TPA and Iso Butyl Benzene from 9,000 TPA to 12,000 TPA in May 2019 with capex of Rs 12.10 crore. During 2020, the Company set up Unit VI, with an installed capacity of 240 MT per annum, which costed Rs 33.83 Crore, to manufacture Pantoprazole and has started its trial production. During 2021, the Company set up an another Unit-7 for manufacturing Metformin with an additional capacity of 7,200 MT per annum for project costing Rs 28 cr. It installed new manufacturing facilities Unit-8 to manufacture Ibuprofen Derivatives and other Pharma Products during FY 2020-21. It increased existing manufacturing facilities of Ethyl Acetate from 87,000 MT per annum to 100,000 MT per annum in Chemical segment during 2021-22.During the year 2022-23, IOL- Foundation was incorporated as wholly owned subsidiary company. The Company set up multi product manufacturing facilities `Unit 10' for manufacturing pharma APIs. It identified to manufacture Fenofibrate, Lamotrigine etc in this unit. Further, it also initiated the project for installation of new manufacturing facilities (Unit-9) for manufacturing Gabapentin and other Pharma products during the year, which is under implementation.In 2023-24, Company commenced the production of Acetic Anhydride in the chemical division mainly for captive consumption as well as merchant sale with installed capacity of 25000 MTPA.During the year 2024-25, the Company commenced a new Unit 11 for Paracetamol production with installed capacity of 10800 MTPA at Barnala. The Company has enhanced the installed capacity of Unit 5 for manufacturing Clopidogrel Bisulphate from 180 MTPA to 240 MTPA.
Managing Director
Varinder Gupta
Registered office Trident Complex, Raikot Road Barnala, Sangrur, Punjab, 148101
FAX :91-01679-244701-07
Background
Incorporation Year 1986
Face Value ₹2.00
Market Lot 1
FAQs on IOL Chemicals & Pharmaceuticals Ltd
How to buy IOL Chemicals & Pharmaceuticals Ltd shares on NSE?
To buy IOL Chemicals & Pharmaceuticals Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the IOL Chemicals & Pharmaceuticals Ltd share price today?
The IOL Chemicals & Pharmaceuticals Ltd share price on NSE is ₹90.32 today.
What is the market cap of IOL Chemicals & Pharmaceuticals Ltd on NSE?
The company has a market capitalization of ₹2651.14.
What is the PE & PB ratio of IOL Chemicals & Pharmaceuticals Ltd?
PE is 23 and PB is 4.
What is the 52 Week High and Low of IOL Chemicals & Pharmaceuticals Ltd shares?
IOL Chemicals & Pharmaceuticals Ltd stock price high: ₹126.66 IOL Chemicals & Pharmaceuticals Ltd stock price low: ₹57.50.